Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer
      Description

      This Phase 1 dose-escalation trial is to determine the safety, tolerability and recommended phase 2 dose of talazoparib in combination with belinostat in subjects with Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer.

      Conditions
      Metastatic Breast CancerMetastatic Castration-resistant Prostate CancerMetastatic Ovarian CarcinomaMetastic or Unresectable Pancreatic Adenocarcinoma
      Talk to us